Allergic rhinitis is a seasonal trouble and off-seasonal problem

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access


Rhinitis (allergic, vasomotor and others) is common inflammatory disease of the nasal cavity. Clinical manifestations of chronic rhinitis, such as nasal obstruction, discharge from the nasal cavity, significantly reduce the quality of life of the patients. Efficacy of modern antihistamine - azelastin in the treatment of seasonal and perennial allergic rhinitis is presented in the article.

Full Text

Restricted Access

About the authors

T G Fedoskova

Institute of Immunology


V M Svistushkin

I.M. Sechenov First Moscow State Medical University

E A Shevchik

I.M. Sechenov First Moscow State Medical University


  1. Лопатин А.С. Ринит. М., «Литтерра». 2010, с. 168-187.
  2. Roger A., Fortea J., Mora S., Artés M. Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis. Expert. Rev. Pharmacoecon Outcomes Res. 2008, v. 8, p. 337-342.
  3. Крюков А.И., Туровский А.Б., Бондарева Г.П., Сёмкина О.В. Принципы лечения аллергического ринита. Медицинский совет. 2013, № 7, с. 42-47.
  4. Свистушкин В.М. Современные аспекты диагностики и лечения аллергического ринита. Consilium medicum. 2007, № 2, с. 15-17.
  5. Никифорова Г.Н., Золотова А.В. Персонифицированный подход к ведению пациентов с аллергическим ринитом: новые возможности базисной терапии. Фарматека. 2004, № 4, с. 14.
  6. Ильина Н.И. Аллергический ринит. Consilium medicum. 2000, № 2, с. 338-344.
  7. Курбачева О.М., Павлова К.С. Аллергический ринит и аллергический конъюнктивит: одна болезнь - две клинические формы. Рос. Аллергол. Журн. 2015, № 3, с. 22-29.
  8. Федеральные клинические рекомендации по диагностике и лечению аллергического ринита. Российская ассоциация аллергологов и клинических иммунологов. М., «Фармарус Принт Медиа». 2014, 124 с.
  9. Федоскова Т.Г. Особенности ведения больных круглогодичным ринитом при острых респираторных инфекциях. Рус. мед. журн. 2011, № 8, с. 518-521.
  10. Соболев А.В., Федоскова Т.Г. Применение деконгестантов в лечении больных аллергическим ринитом. Рос. Аллергол. Журн. 2012, № 2, с. 55-60.
  11. Incorvaia C., Barbera S., Makrì E., Mauro M. Allergic rhinitis: pathology of general interest. Recenti. Prog. Med. 2013, v. 104, p. 116-119.
  12. Saulyte J., Regueira C., Montes-Martínez A. et al. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med. 2014, v. 11, p. 20-26.
  13. Brozek J.L., Bousquet J., Baena-Cagnani C.E. et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J. Allergy Clin. Immunol. 2010, v. 126, p. 466-476.
  14. Bernstein J.A. Azelastine hydrochloride:a review of pharmacology, pharmacokinetics, clinical efficacy and tolerability. Curr. Med. Res. Opin. 2007, v. 23, p. 2441-2452.
  15. Lee C., Corren J. Review of azelastatine nasal spray in the treatment of allergic and non-allergic rhinitis. Expert Opin. Pharmacoter. 2007, v. 8, p. 701-709.
  16. Horak F., Zieglmayer R., Zieglmayer R. et al. Azelastine nasal spray desloratadine tablets in pollen induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficiacy. Curr. Med. Res. Opion. 2006, v. 22, p. 151-157.
  17. Portnoy J., Van Osdol T, Williams P. Evidence-based strategies for treatment of alergic rhinitis. Curr. Allergy Asthma Rep. 2004, v. 4, p. 439-446.
  18. Ciperandi G., Ricca V. Seasonal rhinitis and azelastine: long-or short term treatment? J. Allergy Clin. Immunol. 1997, v. 99, p. 307-310.
  19. Liberman P., Kaliner M.A., Wheeler W.J. Open-label ak F, evaluation of azelastine nasalspray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Curr. Med. Res. Opin. 2005, v. 21, p. 611-618.
  20. Berger W, White M. Efficacy of azelastine nasal in patients with an unsatisfactory response to loratadine. Ann. Allergy Asthma Immunol. 2003, v. 91, p. 205-211.
  21. LaForce C.F., Corren J., Wheeler W.J., Berger W.E. Efficiacy of azelastine nasal spray in seasonal allergic rhinitis patients, who remain symptomatic after treatment with fexofenadine. Ann. Allergy Asthma Immunol. 2004, v. 93, p. 154-159.
  22. Ratner P., Hampel F., Van Bavel J. et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann. Allergy Asthma Immunol. 2008, v. 100, p. 74-81.
  23. Patel P., D’Andrea C., Sacks H. Onset of action of azelastinenasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an enviromental exposure chamber. Am. J. Rhinol. 2007, v. 21. p. 499-503.
  24. Falser N., Wober W., Rahlfs V., Baehre M. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Arzneimittelforschung. 2001, v. 51, p. 387-393.
  25. Behncke V., Alemar G., Kaufman D., Eidelman F. Azelastine nasal spray and fluticasone nasal spray in tratment of geriatric patients who rhinitis. J. Allergy Clin. Immunol. 2006, v. 117, p. 263-267.



Abstract - 26

PDF (Russian) - 0


Article Metrics

Metrics Loading ...


Copyright (c) 2016 Russian Allergological Journal

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies